サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1659303

顧みられない熱帯病診断の世界市場

Neglected Tropical Diseases Diagnosis

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
顧みられない熱帯病診断の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

顧みられない熱帯病診断の世界市場は2030年までに103億米ドルに達する見込み

2024年に74億米ドルと推定される顧みられない熱帯病診断の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には103億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである従来法は、CAGR 4.9％を記録し、分析期間終了時には54億米ドルに達すると予測されます。分子／最新法セグメントの成長率は、分析期間中CAGR 6.3％と推定されます。

米国市場は19億米ドルと推定、中国はCAGR 8.2％で成長予測

米国の顧みられない熱帯病診断市場は、2024年に19億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに22億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と4.4%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の顧みられない熱帯病診断市場- 主要動向と促進要因のまとめ

なぜ顧みられない熱帯病診断が世界ヘルスにとって重要なのか？

顧みられない熱帯病（Neglected Tropical Diseases：NTDs）には、低所得地域の人々が主に罹患するさまざまな感染症が含まれます。NTDsの正確な診断は、デング熱、リーシュマニア症、シャーガス病、住血吸虫症などを含むこれらの病気を制圧し、撲滅するために不可欠です。早期かつ正確な診断は、合併症の予防、トランスミッションの減少、効果的な治療に役立ちます。従来、NTDsの診断は、限られた資源、インフラの欠如、専門的な機器の必要性などの理由から、困難なものでした。しかし、迅速診断検査（RDT）、分子アッセイ、ポイントオブケア機器などの診断技術の革新により、NTDsの診断がより迅速かつ正確になり、遠隔地でも利用しやすくなることで、NTDsの診断に変革が起こりつつあります。

NTD診断市場の主要セグメントは？

診断技術には、血清学的検査、分子検査、画像診断が含まれます。抗体や抗原を検出する血清学的検査は、デング熱やリーシュマニア症のような疾病に広く用いられています。一方、ポリメラーゼ連鎖反応（PCR）のような分子検査は、シャーガス病や住血吸虫症のような疾病を正確に検出するために好まれています。疾患の種類別に見ると、市場は寄生虫性、ウイルス性、細菌性のNTDsをカバーしており、寄生虫性NTDsは罹患地域での流行のため、最大のセグメントとなっています。NTD診断薬の主なエンドユーザーには、病院、診療所、公衆衛生研究所、研究機関などが含まれ、これらの機関は疾病監視や治療戦略の改善に注力しています。

技術革新はどのようにNTD診断を強化しているのか？

技術革新はNTD診断の改善の最前線にあります。迅速診断検査（RDT）は、費用対効果の高いソリューションとして登場し、数分以内に結果が得られるため、ヘルスケアインフラが限られた遠隔地でも迅速な意思決定が可能です。リアルタイムPCRやLAMP（loop-mediated isothermal amplification）などの分子診断法は、高い感度と特異性を提供するため、正確な病気の発見に不可欠です。モバイルベースの診断キットやAIを活用した診断アルゴリズムなどのデジタルヘルスツールも、NTD感染地域における疾病検出、データ収集、報告を強化するために導入されています。これらの技術は診断を向上させるだけでなく、NTD制圧に向けた世界の取り組みにも貢献しています。

顧みられない熱帯病診断市場の成長を促す要因は何か？

顧みられない熱帯病診断市場の成長は、中低所得国におけるNTDsの負担の増加や、正確で手頃な価格の診断薬に対する緊急のニーズなど、いくつかの要因によってもたらされています。より良いサーベイランスと診断を通じてNTDsの制圧と撲滅を目指す政府や非政府組織の取り組みが、革新的な診断ツールの需要を大幅に押し上げています。携帯型診断機器やポイントオブケア検査などの技術的進歩により、NTDの診断は、資源に制約のある環境においても、より身近なものとなっています。さらに、世界保健機関（WHO）やビル・アンド・メリンダ・ゲイツ財団（Bill &Melinda Gates Foundation）などの世界・ヘルス・イニシアチブによる国際的な資金援助が、NTD診断の研究開発を促進しています。また、一次ヘルスケアシステムへの診断薬統合への注目が高まっていることも、市場の成長を後押ししています。

セグメント

手法（従来型、分子/最新型）;サービスタイプ（集中型、ポイントオブケア）;エンドユース（臨床検査室、病院・クリニック、在宅ヘルスケア）

調査対象企業の例（注目の33社）

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics., Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22362

Global Neglected Tropical Diseases Diagnosis Market to Reach US$10.3 Billion by 2030

The global market for Neglected Tropical Diseases Diagnosis estimated at US$7.4 Billion in the year 2024, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Molecular / Modern Method segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 8.2% CAGR

The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Neglected Tropical Diseases Diagnosis Market - Key Trends and Drivers Summarized

Why Is Neglected Tropical Diseases Diagnosis Crucial for Global Health?

Neglected Tropical Diseases (NTDs) encompass a range of infectious diseases that predominantly affect populations in low-income regions. Accurate diagnosis of NTDs is critical for controlling and eradicating these diseases, which include conditions like dengue, leishmaniasis, Chagas disease, and schistosomiasis. Early and precise diagnosis helps prevent complications, reduces transmission, and aids in effective treatment. Traditionally, diagnosing NTDs has been challenging due to limited resources, lack of infrastructure, and the need for specialized equipment. However, innovations in diagnostic technologies, such as rapid diagnostic tests (RDTs), molecular assays, and point-of-care devices, are transforming NTD diagnosis by making it faster, more accurate, and accessible in remote areas.

What Are the Key Segments in the NTD Diagnosis Market?

Diagnostic techniques include serological tests, molecular tests, and imaging-based diagnostics. Serological tests, which detect antibodies or antigens, are widely used for diseases like dengue and leishmaniasis, while molecular tests, such as polymerase chain reaction (PCR), are preferred for their accuracy in detecting diseases like Chagas and schistosomiasis. In terms of disease type, the market covers parasitic, viral, and bacterial NTDs, with parasitic NTDs being the largest segment due to their prevalence in affected regions. Major end-users of NTD diagnostics include hospitals, clinics, public health laboratories, and research institutions that are focused on improving disease surveillance and treatment strategies.

How Are Technological Innovations Enhancing NTD Diagnosis?

Technological advancements are at the forefront of improving NTD diagnosis. Rapid diagnostic tests (RDTs) have emerged as a cost-effective solution, offering results within minutes and facilitating quick decision-making in remote areas with limited healthcare infrastructure. Molecular diagnostics, such as real-time PCR and loop-mediated isothermal amplification (LAMP), offer high sensitivity and specificity, making them essential for accurate disease detection. Digital health tools, including mobile-based diagnostic kits and AI-powered diagnostic algorithms, are also being deployed to enhance disease detection, data collection, and reporting in NTD-affected regions. These technologies not only improve diagnosis but also contribute to global efforts toward NTD elimination.

What Factors Are Driving the Growth in the Neglected Tropical Diseases Diagnosis Market?

The growth in the Neglected Tropical Diseases Diagnosis market is driven by several factors, including the increasing burden of NTDs in low- and middle-income countries and the urgent need for accurate, affordable diagnostics. Government and non-governmental organizations' efforts to control and eliminate NTDs through better surveillance and diagnosis have significantly boosted the demand for innovative diagnostic tools. Technological advancements, such as portable diagnostic devices and point-of-care testing, have made NTD diagnosis more accessible, even in resource-constrained settings. Additionally, international funding from global health initiatives, such as the World Health Organization and the Bill & Melinda Gates Foundation, is promoting research and development in NTD diagnostics. The increasing focus on integrating diagnostics into primary healthcare systems is also driving market growth.

SCOPE OF STUDY:

The report analyzes the Neglected Tropical Diseases Diagnosis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (Conventional, Molecular / Modern); Service Type (Centralized, Point of Care); End-Use (Clinical Labs, Hospitals & Clinics, Home Healthcare)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics., Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • Neglected Tropical Diseases Diagnosis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early and Accurate Diagnosis Spurs Growth in Neglected Tropical Diseases (NTD) Diagnosis Market
    • Technological Advancements in Rapid Diagnostic Tests and Point-of-Care Devices Strengthen Business Case for Adoption
    • Growing Focus on Enhancing Surveillance and Control of NTDs Expands Addressable Market
    • Expansion of NTD Diagnosis in Public Health Programs and Remote Clinics Fuels Market Growth
    • Increasing Adoption of NTD Diagnosis in Low- and Middle-Income Countries Expands Market Opportunities
    • Technological Innovations in Molecular and Serological Diagnostic Tools Propel Market Expansion
    • Rising Focus on Reducing Disease Burden and Mortality Rates Drives Demand for NTD Diagnosis
    • Growing Use of NTD Diagnosis in Research, Epidemiology, and Field Studies Expands Market Potential
    • Focus on Meeting WHO Guidelines and Global Health Initiatives Strengthens Market for NTD Diagnosis
    • Technological Advancements in Multiplex Testing and Portable Diagnostic Kits Propel Market Growth
    • Increasing Focus on Integrating NTD Diagnosis with Telemedicine and Digital Health Platforms Drives Adoption
    • Rising Demand for NTD Diagnosis in Humanitarian Aid and Emergency Response Settings Strengthens Global Market
    • Expansion of NTD Diagnosis in Veterinary Health and Zoonotic Disease Surveillance Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular / Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular / Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Molecular / Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Centralized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Centralized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Centralized by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Point of Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Point of Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Point of Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Clinical Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Clinical Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Neglected Tropical Diseases Diagnosis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • JAPAN
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • CHINA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • EUROPE
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • FRANCE
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • GERMANY
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • INDIA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030
  • AFRICA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2015, 2025 & 2030

IV. COMPETITION